Sanofi Plans to Split Consumer Health Unit to Narrow Focus

The platform seeks to address limitations associated with existing cancer therapies and has generated preclinical candidates targeting multiple KRAS-driven solid tumor indications.

A routine provision in M&A agreements can expose sellers to uncapped liability—making precise drafting of “fraud” critical to post-closing risk allocation.

Atraverse Medical develops tools for cardiac procedures.